Interactions of peptide amidation and copper: novel biomarkers and mechanisms of neural dysfunction.
about
Canine Models for Copper Homeostasis Disorders60 YEARS OF POMC: From POMC and α-MSH to PAM, molecular oxygen, copper, and vitamin CCopper signaling in the mammalian nervous system: synaptic effectsATP7A-related copper transport diseases-emerging concepts and future trendsEarly eukaryotic origins for cilia-associated bioactive peptide-amidating activity.Elimination of Kalrn expression in POMC cells reduces anxiety-like behavior and contextual fear learning.In vivo and in vitro analyses of amygdalar function reveal a role for copperPam heterozygous mice reveal essential role for Cu in amygdalar behavioral and synaptic functionHaploinsufficiency in peptidylglycine alpha-amidating monooxygenase leads to altered synaptic transmission in the amygdala and impaired emotional responses.Genetic determinants of amidating enzyme activity and its relationship with metal cofactors in human serumEvaluation of candidate genes from orphan FEB and GEFS+ loci by analysis of human brain gene expression atlasesProbing the production of amidated peptides following genetic and dietary copper manipulations.Maternal iron supplementation attenuates the impact of perinatal copper deficiency but does not eliminate hypotriiodothyroninemia nor impaired sensorimotor development.Peptidylgycine α-amidating monooxygenase and copper: a gene-nutrient interaction critical to nervous system function.Peptidylglycine α-amidating monooxygenase heterozygosity alters brain copper handling with region specificity.Limbic system pathologies associated with deficiencies and excesses of the trace elements iron, zinc, copper, and selenium.Prediction of protein amidation sites by feature selection and analysis.Scientific Opinion on Dietary Reference Values for copperNeurotoxicity of Copper.
P2860
Q26767292-C55081FE-49CA-4326-80E4-E0241F0FA7ECQ26775879-C09D934D-A55D-44A8-9A0F-563A30E88244Q26849773-D93D604B-15B4-4E3A-A42B-CB19EFEBB518Q28302938-8726B1A1-B4BD-43B9-82F1-F16EF3E538EFQ30353921-C48CAD30-2FEB-494C-8EF6-9F09ADAD4106Q30407136-DED2328B-29CC-499B-92BB-C58261E17E65Q30411908-BFD162AB-3E7F-45E4-9B9B-64697D32387BQ30412889-320395E9-10F7-4055-8E4E-C82BA07EEAB7Q30475836-8B422EBE-94BD-4243-B530-0FBE19673603Q33960064-14B00588-2E3E-43A5-B79F-5FEDF559E740Q33999205-D3CF81BC-6F34-4EB5-ACEB-13A422252BC6Q34110252-94F433A3-6E6E-4BDC-8FF4-12B3D80EA4A8Q36204664-79C0BD2A-9250-4E23-8817-D726A2F80D29Q37066112-0BAD190F-E1D2-4DE6-86CE-0104608F9181Q37610172-ACED215D-25BC-4CF1-BF28-2D27B6FF4464Q38064534-4FC18563-2CAF-4D41-9B49-474AFA6D1499Q45759852-64827B85-473F-47BE-975C-B629EF10C1C4Q47157342-1ECAC683-B5F4-4562-B047-A75E16F0BCCDQ48120135-57C06914-D818-47FB-9C83-70985BFECA68
P2860
Interactions of peptide amidation and copper: novel biomarkers and mechanisms of neural dysfunction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interactions of peptide amidat ...... hanisms of neural dysfunction.
@en
Interactions of peptide amidat ...... hanisms of neural dysfunction.
@nl
type
label
Interactions of peptide amidat ...... hanisms of neural dysfunction.
@en
Interactions of peptide amidat ...... hanisms of neural dysfunction.
@nl
prefLabel
Interactions of peptide amidat ...... hanisms of neural dysfunction.
@en
Interactions of peptide amidat ...... hanisms of neural dysfunction.
@nl
P2093
P2860
P1476
Interactions of peptide amidat ...... hanisms of neural dysfunction.
@en
P2093
Betty A Eipper
Danielle Bousquet-Moore
Eduardo A Nillni
Joseph R Prohaska
Richard E Mains
Traci Czyzyk
William C Wetsel
P2860
P304
P356
10.1016/J.NBD.2009.09.016
P577
2009-10-06T00:00:00Z